Plain-English translation of NCT05662696 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a smartphone app called Raabta (meaning 'a connection' in Urdu) designed to help pregnant women at high risk for preeclampsia monitor their blood pressure at home every day. The app connects to a home blood pressure monitor and sends alerts to both you and your healthcare provider if your readings are concerning or if you report symptoms. The goal is to catch early warning signs of preeclampsia between your regular clinic visits so you can get help faster.
Preeclampsia is a serious pregnancy complication that can be life-threatening if not caught early. Right now, most monitoring happens only during scheduled clinic visits, which means dangerous changes in blood pressure can be missed. This app aims to fill that gap by giving you and your doctor more information and faster alerts, especially in Pakistan where access to frequent clinic visits can be challenging.
You likely qualify if…
You likely don't qualify if…
You would receive a free Bluetooth-enabled home blood pressure monitor and download the Raabta app on your smartphone. Each day, you would take your blood pressure at home using the monitor, which automatically sends the reading to the app. The app will send you messages and alerts based on your readings and any symptoms you report, and your healthcare provider will also receive alerts if something concerning shows up. The study will include interviews with you, your partner or caregiver, and your healthcare providers to understand how well the app works in daily life.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Pakistan